Devon Shedlock
18Patents
5h-index
6Co-inventors
55Inventor score
Filing activity: Jan 31, 2012 → Jun 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9597388B2 | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same | Chemistry; Metallurgy | 10 | Active |
| US9243041B2 | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US10513686B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 7 | Active |
| US10329543B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 5 | Active |
| US11028143B2 | Enhanced antigen presenting ability of RNA CAR T cells by co-introduction of costimulatory molecules | Emerging Cross-Sectional Technologies | 5 | Active |
| US10034930B2 | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same | Chemistry; Metallurgy | 4 | Active |
| US10415016B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 3 | Active |
| US10765733B2 | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same | Chemistry; Metallurgy | 2 | Active |
| US11377480B2 | Inducible caspases and methods for use | Chemistry; Metallurgy | 2 | Active |
| US11802269B2 | Superpiggybac transposase compositions | Chemistry; Metallurgy | 1 | Active |
| US9994619B2 | Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11718656B2 | Inducible caspases and methods for use | Chemistry; Metallurgy | 0 | Active |
| US12385061B2 | Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression | Chemistry; Metallurgy | 0 | Active |
| US12358966B2 | Inducible caspases and methods for use | Chemistry; Metallurgy | 0 | Active |
| US12162922B2 | Enhanced antigen presenting ability of RNA car T cells by co-introduction of costimulatory molecules | Emerging Cross-Sectional Technologies | 0 | Active |
| US12415844B2 | BCMA specific VCAR compositions and methods for use | Emerging Cross-Sectional Technologies | 0 | Active |
| US11744861B2 | Compositions and methods for selective elimination and replacement of hematopoietic stem cells | Chemistry; Metallurgy | 0 | Active |
| US11723969B2 | Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.